AGP Executive Report
Last update: 5 hours agoPerioperative Mental Health: A Stanford-led study in Anesthesiology reports a five-step “anesthesia dreaming” protocol that helps patients recall more positive, soothing dreams and boosts satisfaction, with a key element being about 10 minutes of low-stimulation time during emergence. Drug Policy & Access: A U.S. FTC settlement with CVS Caremark spotlights pharmacy benefit manager practices that inflate drug prices via rebates, aiming to redirect billions in savings to patients and push PBMs toward fairer reimbursement. Regulation Shake-Up: Trump’s executive order recommends splitting childhood vaccines into single-disease visits and presses states to narrow school requirements to a smaller federal list, raising major operational questions for primary care. Pharma Dealmaking: Jazz Pharmaceuticals agreed to buy Actio Biosciences for up to $1.32B to expand its epilepsy pipeline, including ABS-1230 for KCNT1-related pediatric epilepsy. Clinical Care Update: A JAMA Otolaryngology trial finds that a short post-tonsillectomy course of oral dexamethasone reduces pain and opioid use in children. Infectious Disease Watch: Suffolk County, New York, confirmed a fourth tularemia (“rabbit fever”) case on Long Island as tick-bite visits hit near-decade highs. Healthcare Innovation: North Carolina and nationwide efforts show AI is being integrated into care workflows, from diagnostics to drafting clinician communications.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.